These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25308737)

  • 1. Renal interstitial mast cell counts differ across classes of proliferative lupus nephritis.
    Kaczmarczyk K; Kosalka J; Soja J; Kuzniewski M; Musial J; Okon K
    Folia Histochem Cytobiol; 2014; 52(3):218-24. PubMed ID: 25308737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal interstitial mast cell count is significantly higher in membranoproliferative glomerulonephritis than in class IV lupus nephritis.
    Kaczmarczyk K; Musiał J; Soja J; Kuźniewski M; Gala-Błądzińska A; Białas M; Okoń K
    Pol J Pathol; 2015 Jun; 66(2):149-53. PubMed ID: 26247528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells, TGF-beta1 and myofibroblasts expression in lupus nephritis outcome.
    Ravinal RC; Costa RS; Coimbra TM; Dantas M; dos Reis MA
    Lupus; 2005; 14(10):814-21. PubMed ID: 16302676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system.
    Yu F; Wu LH; Tan Y; Li LH; Wang CL; Wang WK; Qu Z; Chen MH; Gao JJ; Li ZY; Zheng X; Ao J; Zhu SN; Wang SX; Zhao MH; Zou WZ; Liu G
    Kidney Int; 2010 May; 77(9):820-9. PubMed ID: 20182417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
    Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
    J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
    Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P
    Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells in systemic and cutaneous lupus erythematosus.
    Kaczmarczyk-Sekuła K; Dyduch G; Kostański M; Wielowieyska-Szybińska D; Szpor J; Białas M; Okoń K
    Pol J Pathol; 2015 Dec; 66(4):397-402. PubMed ID: 27003772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis.
    Hill GS; Delahousse M; Nochy D; Bariéty J
    Kidney Int; 2005 Nov; 68(5):2288-97. PubMed ID: 16221231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
    Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
    Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of interstitial mast cells in lupus and non-lupus membranous glomerulopathy.
    Danilewicz M; Wagrowska-Danilewicz M
    Pol J Pathol; 2001; 52(4):211-7. PubMed ID: 11915183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased mast cell density in renal interstitium is correlated with relative interstitial volume, serum creatinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis.
    Okoń K; Stachura J
    Pol J Pathol; 2007; 58(3):193-7. PubMed ID: 18074865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesis.
    Jeruc J; Jurcić V; Vizjak A; Hvala A; Babic N; Kveder R; Praprotnik S; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):702-6. PubMed ID: 11020960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis.
    Park MH; D'Agati V; Appel GB; Pirani CL
    Nephron; 1986; 44(4):309-19. PubMed ID: 3540691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells in the kidney biopsies of pediatric patients with lupus nephritis.
    Santos SS; Ramos CM; Monteiro MLGR; Machado JR; Reis MA; Corrêa RRM; Rocha LP
    J Bras Nefrol; 2020 Mar; 42(1):59-66. PubMed ID: 32023339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased density of interstitial mast cells in amyloid A renal amyloidosis.
    Tóth T; Tóth-Jakatics R; Jimi S; Takebayashi S
    Mod Pathol; 2000 Sep; 13(9):1020-8. PubMed ID: 11007043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; Okoń K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
    Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
    Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.